Sili Bio's half -annual net profit in 2022 decreased 11.70% year -on -year

On August 25, Xili Biological (Code: 871574.NQ) released the performance report of the 2022 Half -Annual Report.

From January 1, 2022-June 30, 2022, the company realized operating income of 2.771 million yuan, a year-on-year decrease of 11.38%, net profit of 1.24 million yuan, a year-on-year decrease of 11.70%, and the basic earnings per share were 0.0460 yuan.

The company's industry is biological products.

During the company's reporting period, the total assets at the end of the period were 46.2415 million yuan, operating profit was 1.0605 million yuan, and the accounts receivable were 8509,800 yuan. The net cash flow generated by operating activities was -201,100 yuan.The cash was 2.9231 million yuan.

Xili Biological, the company's full name is Yunnan Xilili Biotechnology Co., Ltd., was established on July 10, 2007. It is currently general manager Wei Guozhu. The main business is the research and development, production, sales and technical services of natural activity compounds.

- END -